Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 303 participants.

Also called NCT01826994

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose diagnostic
Phase
Not applicable
Enrolled
  • 303 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01826994
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Belgium, Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01826994. Allocation not applicable; no masking; primary purpose diagnostic. Start 2013-09 (registry gives no type); primary completion 2016-12 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Incremental Value of Point of Care H-FABP Testing in Primary Care Patients Suspected of Acute Coronary Syndrome
Acronym
RAPIDA
Condition
Acute Coronary Syndrome
Condition
Angina Pectoris, Unstable
Condition
Angina Pectoris, Stable
Condition
Thoracic Diseases
Intervention (Device)
heart type fatty acid binding protein testing
Lead sponsor
Maastricht University Medical Center (class: other)
Collaborator
FABPulous B.V. (class: other)

Record details

Record id
cardio:ct-nct01826994
Content hash
790fd299b47416f83c8b2f2f9c856c29ed384666d647a4135758101ace85dcc5